Connection
Shi-Ming Tu to Receptors, Platelet-Derived Growth Factor
This is a "connection" page, showing publications Shi-Ming Tu has written about Receptors, Platelet-Derived Growth Factor.
|
|
Connection Strength |
|
|
|
|
|
0.096 |
|
|
|
-
Mathew P, Tannir N, Tu SM, Wen S, Guo CC, Marcott V, Bekele BN, Pagliaro L. Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib. Cancer Chemother Pharmacol. 2011 Oct; 68(4):889-96.
Score: 0.096